In recent years, "medication abortions,” also known as “chemical abortions,” have skyrocketed. This abortion method occurs when a pregnant woman takes two pills, mifepristone and misoprostol, to terminate the life of her unborn child. The first pill stops the baby from growing, killing it, and the latter expunges the unborn child from the mother’s body.
According to the most recent data provided by the pro-abortion Guttmacher Institute, 63 percent of abortions of all clinician-provided abortions in 2023 in states without total abortion bans were medication abortions.
One topic the pro-abortion lobby doesn’t touch on is the amount of women who suffer from dangerous health effects as a result of taking mifepristone, the “abortion pill.”
According to a report published this week, nearly 11 percent of women who have taken a chemical abortion pill in recent years have experienced a serious health event as a result. This ranges from infections to sepsis.
According to the American Association of Pro Life OBGYNs (AAPLOG), that is 22 times higher than what is reported by the US Food and Drug Administration.
The study, which analyzes 866,727 drug-induced abortions 2017-2023, finds that 10.9% of women who take these drugs experience severe adverse events e.g. hemorrhage, infection, & sepsis within 45 days. This means that 71k women likely experienced these complications in 2023.
— AAPLOG (@aaplog) April 28, 2025
2/5
Women deserve to know the potentially life-threatening risks of these drugs. They deserve better than to be left to undergo dangerous drug-induced abortions with minimal medical supervision.
— AAPLOG (@aaplog) April 28, 2025
4/5
Read the study: https://t.co/mockWtiK2h
— AAPLOG (@aaplog) April 28, 2025
5/5
According to the New York Post, the FDA previously stated that fewer than 0.5 percent of women experience complications from Mifeprex, specifically.
“10.93 percent of women experience sepsis, infection, hemorrhaging, or another serious or life-threatening adverse event within 45 days following a mifepristone abortion, far greater than the summary figure of “less than 0.5 percent” in clinical trials reported on the drug label,” the study states. The study analyzed real-world insurance claims data for 865,727 prescribed mifepristone abortions.
“This should serve as an urgent safety signal for the FDA and is more consistent with what I see in clinical practice,” Dr. Christina Francis, a board-certified obstetrician and CEO of AAPLOG, told the Post.
“As a board-certified OB/GYN who has practiced for approximately two decades, I have cared for many women who have been lied to about the safety of abortion drugs and suffered significant complications from them,” she continued.
“Women deserve fully informed consent about the dangers of these drugs and this data shows that more than 1 in 10 women who take them will suffer a severe complication,” she added. “This is a public health crisis that should be further investigated immediately by the FDA — especially in light of its systematic removal of medical oversight from these drugs.”
Susan B. Anthony Pro-Life America President Marjorie Dannenfelser reacted to the study, as well.
“While the abortion industry and Democrat politicians push the lie that abortion drugs are ‘safer than Tylenol,’ a growing body of evidence suggests these risky drugs are much more dangerous than advertised. The harm to women and girls as well as their unborn children simply can’t be ignored. Even in the corporate media, reports have surfaced of at least three women dying in recent years after drug-induced abortions. All three deaths occurred after Biden’s FDA removed critical safety protections for women and girls, including the requirement to see a doctor in person – making the deadly drugs widely available by mail-order to abusers and traffickers who assault and poison their victims. Planned Parenthood now boasts of distributing abortion drugs by app, ‘completely free of face-to-face interaction with a clinician,’ even though their own data show more than twice as many adverse events than the total reported to the FDA. The new reports uncovered today are disturbing. We urge the FDA under new leadership to take a fresh, hard look at the data and reinstate strong safeguards for women and girls," she told Townhall.
